Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Maraviroc | |
| Synonyms |
|
|
| Definitions |
A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C73144 |
|
| CAS_Registry |
376348-65-1
|
|
| CHEBI_ID |
CHEBI:63608
|
|
| Chemical_Formula |
C29H41F2N5O
|
|
| code |
C73144
|
|
| Contributing_Source |
CTRP FDA
|
|
| definition |
A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction.
|
|
| Display_Name |
Maraviroc
|
|
| FDA_UNII_Code |
MD6P741W8A
|
|
| Has_Target | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 http://purl.obolibrary.org/obo/NCIT_C173381 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
| label |
Maraviroc
|
|
| Legacy Concept Name |
Maraviroc
|
|
| NCI_Drug_Dictionary_ID |
696304
|
|
| PDQ_Closed_Trial_Search_ID |
696304
|
|
| PDQ_Open_Trial_Search_ID |
696304
|
|
| Preferred_Name |
Maraviroc
|
|
| prefixIRI |
NCIT:C73144
|
|
| prefLabel |
Maraviroc
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C1667052
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping